Product Reports Resources Pricing Login Book a demo

Transcarent

Health Tech & Medtech · San Francisco, United States · Founded 2020

New consumer-directed health and care platform for employees of self-insured employers and their families

Talent graph

Transcarent's talent

Book a demo to see the people
Employees mapped 836 incl. 14 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

17 investors on Transcarent's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage
7wire Ventures
Jove Equity Partners
General Catalyst
Alta Partners
Series B+ 13 investors entered at this stage
Merck Global Health Innovation Fund
Intermountain Healthcare
Kleiner Perkins
Ally Bridge Group
Kinnevik
Rush University Medical Center
Memorial Hermann Health System
Human Capital
Threshold Ventures
GreatPoint Ventures
Leaps by Bayer
Geodesic Capital
Northwell Health

Global footprint

Where Transcarent has talent and traffic

Workforce by country
6 countries with
team presence
🇺🇸 United States97.1%
🇨🇿 Czech Republic0.9%
🇲🇽 Mexico0.8%
🇷🇸 Serbia0.5%
🇨🇦 Canada0.5%
Top 5 of 6 shown
Web traffic by country
18K monthly visits
across markets
🇺🇸 United States90%
🇮🇳 India3.9%
🇵🇭 Philippines2.8%
🇨🇦 Canada2.2%
Top 4 markets shown

Patent intelligence

$2M patent portfolio · 7 active families

Estimated portfolio value
$2M
0.10% of valuation · 22.4× smaller than top peer Teladoc ($50M)
7 active patent families
Where Transcarent innovates Burst errorCommunications systemComputer basedElectronic equipmentEncoder

Where Transcarent concentrates vs peers

Each axis is a top-10 topic across Transcarent and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Transcarent's 3 investments and acquisitions.

Every disclosed deal where Transcarent appeared as a backer or acquirer, 2020–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Transcarent's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Transcarent deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Transcarent's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Transcarent

        An AI-synthesized read of the highest-engagement posts about Transcarent on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Transcarent on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.